KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 120 filers reported holding KEROS THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $224,981 | +279.7% | 4,923 | +450.1% | 0.00% | +300.0% |
| Q1 2024 | $59,249 | -82.0% | 895 | -89.2% | 0.00% | -75.0% |
| Q4 2023 | $328,497 | +1517.6% | 8,262 | +1197.0% | 0.00% | +300.0% |
| Q3 2023 | $20,308 | -74.3% | 637 | -67.6% | 0.00% | -66.7% |
| Q2 2023 | $78,994 | +164470.8% | 1,966 | +72.5% | 0.00% | +50.0% |
| Q1 2023 | $48 | +108.7% | 1,140 | +134.6% | 0.00% | +100.0% |
| Q4 2022 | $23 | -100.0% | 486 | -82.9% | 0.00% | -50.0% |
| Q3 2022 | $107,000 | +7.0% | 2,843 | -21.7% | 0.00% | 0.0% |
| Q2 2022 | $100,000 | +376.2% | 3,632 | +863.4% | 0.00% | – |
| Q1 2022 | $21,000 | -78.6% | 377 | -77.5% | 0.00% | -100.0% |
| Q4 2021 | $98,000 | +415.8% | 1,677 | +246.5% | 0.00% | – |
| Q3 2021 | $19,000 | -55.8% | 484 | -52.1% | 0.00% | -100.0% |
| Q2 2021 | $43,000 | +22.9% | 1,010 | +79.7% | 0.00% | 0.0% |
| Q1 2021 | $35,000 | +150.0% | 562 | +192.7% | 0.00% | – |
| Q4 2020 | $14,000 | -94.3% | 192 | -97.0% | 0.00% | -100.0% |
| Q3 2020 | $247,000 | +1800.0% | 6,399 | +1744.1% | 0.00% | +200.0% |
| Q2 2020 | $13,000 | – | 347 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 292,833 | $17,134,000 | 5.65% |
| Deep Track Capital, LP | 1,300,000 | $76,063,000 | 5.37% |
| Octagon Capital Advisors LP | 340,214 | $19,906,000 | 3.87% |
| Opaleye Management Inc. | 265,750 | $15,549,000 | 3.30% |
| First Light Asset Management, LLC | 552,098 | $32,303,000 | 2.31% |
| Altium Capital Management LP | 116,000 | $6,787,000 | 1.87% |
| Nantahala Capital Management | 796,698 | $46,615,000 | 1.64% |
| Orbimed Advisors | 1,679,417 | $98,263,000 | 1.26% |
| Darwin Global Management, Ltd. | 111,500 | $6,524,000 | 1.00% |
| Parkman Healthcare Partners LLC | 69,861 | $4,088,000 | 0.90% |